Verastem (VSTM) Net Income towards Common Stockholders (2011 - 2026)

Verastem's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders changed 0.11% year-over-year to -$44.5 million in Q1 2026; TTM through Mar 2026 was -$139.5 million, a 5.54% decrease from a year earlier, with the FY2025 full-year figure at -$165.5 million, down 26.66% from the prior year.
• Net Income towards Common Stockholders fell to -$44.5 million in Q1 2026 per VSTM's latest filing, from $3.2 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $3.2 million in Q4 2025 and bottomed at -$54.0 million in Q2 2025.
• The 5-year median for Net Income towards Common Stockholders is -$22.0 million (2022), against an average of -$27.4 million.
• Biggest YoY gain for Net Income towards Common Stockholders was 110.02% in 2025; the steepest drop was 192.7% in 2025.
• Year by year, Net Income towards Common Stockholders stood at -$16.8 million in 2022, then plunged by 76.25% to -$29.6 million in 2023, then retreated by 7.96% to -$32.0 million in 2024, then soared by 110.02% to $3.2 million in 2025, then tumbled by 1487.92% to -$44.5 million in 2026.
• Per Business Quant, the three latest VSTM Net Income towards Common Stockholders figures stand at -$44.5 million (Q1 2026), $3.2 million (Q4 2025), and -$44.3 million (Q3 2025).